Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Schmidt-Braekling, T; Streitbuerger, A; Gosheger, G; Boettner, F; Nottrott, M; Ahrens, H; Dieckmann, R; Guder, W; Andreou, D; Hauschild, G; Moellenbeck, B; Waldstein, W; Hardes, J.
Silver-coated megaprostheses: review of the literature.
Eur J Orthop Surg Traumatol. 2017; 27(4): 483-489. Doi: 10.1007/s00590-017-1933-9
PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Andreou Dimosthenis
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Periprosthetic infection remains one of the most serious complications following megaendoprostheses. Despite a large number of preventive measures that have been introduced in recent years, it has not been possible to further reduce the rate of periprosthetic infection. With regard to metallic modification of implants, silver in particular has been regarded as highly promising, since silver particles combine a high degree of antimicrobial activity with a low level of human toxicity. This review provides an overview of the history of the use of silver as an antimicrobial agent, its mechanism of action, and its clinical application in the field of megaendoprosthetics. The benefits of silver-coated prostheses could not be confirmed until now. However, a large number of retrospective studies suggest that the rate of periprosthetic infections could be reduced by using silver-coated megaprostheses.
Find related publications in this database (using NLM MeSH Indexing): Coated Materials, Biocompatible - administration & dosage; Female - administration & dosage; Humans - administration & dosage; Incidence - administration & dosage; Male - administration & dosage; Prognosis - administration & dosage; Prostheses and Implants - standards, trends; Prosthesis Design - administration & dosage; Prosthesis Implantation - adverse effects, methods; Prosthesis-Related Infections - epidemiology, prevention & control; Risk Assessment - administration & dosage; Silver - pharmacology; Treatment Outcome - administration & dosage